Form 8-K - Current report:
SEC Accession No. 0001326732-25-000032
Filing Date
2025-03-05
Accepted
2025-03-05 16:03:45
Documents
13
Period of Report
2025-02-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20250227.htm   iXBRL 8-K 31392
  Complete submission text file 0001326732-25-000032.txt   155472

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20250227.xsd EX-101.SCH 1779
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20250227_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20250227_pre.xml EX-101.PRE 12506
15 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20250227_htm.xml XML 2728
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 25710825
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)